Background In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant
of Concern (VoC) which is now named B.1.1.7. Based on initial data from the UK and later …

Background Administration of anti-CD19 chimeric antigen receptor T-cell (CART19)
immunotherapy for large B-cell lymphomas (LBCLs), a subset of non-Hodgkin lymphoma (NHL), …

S assp. org MAY 2021 PROFESSIONAL SAFETY PSJ 17 able to complete before the pandemic
to their current output and realize that they are getting less done than before due to that …

Lymphodepletion (LD) is an integral component of chimeric antigen receptor T-cell (CART)
immunotherapies. In this study, we compared the safety and efficacy of bendamustine (Benda…

Bendamustine has been retrospectively shown to be an effective and safe lymphodepletion
regimen prior to the anti-CD19 chimeric antigen receptor T cell (CART) products …

Genome‐wide genotyping and Bayesian inference method (BORICE) were employed to
estimate outcrossing rates and paternity in two small plant populations of Tolpis succulenta (…

Small-molecule probes can illuminate biological processes and aid in the assessment of
emerging therapeutic targets by perturbing biological systems in a manner distinct from other …

The explosion of map use in the past few decades as part of everyday activities, accelerated
through the digital production and dissemination of maps and the availability of low-cost, …

In 2016, the Transplantation Society of Australia and New Zealand, with the support of the
Australian Government Organ and Tissue authority, commissioned a literature review on the …

Interleukin 1, an immune response-generated cytokine that stimulates astrocyte proliferation
and reactivity (astrogliosis), was present in up to 30 times as many glial cells in tissue …